Antihyperglycemic, Vasodilator, and Diuretic Activities of Microencapsulated Bioactive Product from Moringa stenopetala Leaves Extract
Table 6
Electrolyte extraction in the treated rats using the microencapsulated bioactive product.
Treatment
Excreted electrolytes (mmol/L)
Natriuretic activity
Saluretic activity
Carbonic anhydrase inhibition
Saluretic index
Na+
K+
Cl−
Na+/K+
Na+ + Cl−
Cl−/(Na+ + K+)
Na+
K+
Cl−
Dose 500 mg/kg
137.83 ± 14.82bc
79.73 ± 3.36bc
166.67 ± 14.35ab
1.73 ± 0.38a
304.50 ± 29.13ab
0.76 ± 0.04a
1.52
1.20
1.34
Dose 750 mg/kg
180.50 ± 9.40ab
104.15 ± 8.75ab
245.35 ± 21.89a
1.76 ± 0.20a
425.85 ± 30.76a
0.86 ± 0.08a
1.99
1.57
1.97
Dose 1000 mg/kg
187.33 ± 15.33ab
103.32 ± 8.32ab
243.00 ± 31.92a
1.82 ± 0.19a
430.33 ± 46.76a
0.82 ± 0.12a
2.06
1.56
1.96
Positive control
191.00 ± 13.81a
113.62 ± 9.19a
253.37 ± 27.23a
1.73 ± 0.38a
444.37 ± 46.76a
0.82 ± 0.13a
2.10
1.72
2.04
Normal control
90.83 ± 5.07c
66.25 ± 4.97c
124.28 ± 7.16b
1.42 ± 0.40a
215.12 ± 11.80b
0.79 ± 0.06a
1
1
1
All values indicated in different superscript letters in each column indicate the presence of significant differences () in the dose of the microencapsulated product and control groups.